Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Fred Hassan


  • Director at Amgen Inc (AMGN), 2019-05-07
  • Director at Intrexon Corp (XON), 2019-03-26
  • at Warner Media Llc (TWX), 2018-06-18
  • Director at Valeant Pharmaceuticals International Inc. (VRX), 2013-09-03
  • Director at Avon Products Inc (AVP), 2012-05-07
  • Officer, Director at Merck & Co. Inc. (SGP), 2009-11-04
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
XON $29.02 6,900 Director 6,900 2016-12-01 Filing
AMGN $165.50 10 Director 3,582 2015-08-19 Filing
AMGN $166.64 3,000 Director 3,572 2015-08-19 Filing
VRX $99.01 51,000 Director 53,969 2013-08-29 Filing
TWX $29.83 34,000 Director 34,000 2010-03-03 Filing